These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7205248)

  • 41. Pergolide, a potent long-acting dopamine-receptor agonist.
    Lemberger L; Crabtree R; Callaghan JT
    Clin Pharmacol Ther; 1980 May; 27(5):642-51. PubMed ID: 7189453
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Desensitization of the dopaminergic inhibition of pituitary luteinizing hormone release by prolactin in ovariectomized rats.
    Beck W; Wuttke W
    J Endocrinol; 1977 Jul; 74(1):67-74. PubMed ID: 874418
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuroendocrinological investigations during sleep deprivation in depression. II. Longitudinal measurement of thyrotropin, TH, cortisol, prolactin, GH, and LH during sleep and sleep deprivation.
    Baumgartner A; Riemann D; Berger M
    Biol Psychiatry; 1990 Oct; 28(7):569-87. PubMed ID: 2171684
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stimulatory control of prolactin by dopamine.
    Brown GM; Seggie JA
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):355-8. PubMed ID: 6891802
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of sulpiride, an atypical neuroleptic, on apomorphine-induced growth hormone secretion.
    Nair NP; Lal S; Iskandar HI; Etienne P; Wood PL; Guyda H
    Brain Res Bull; 1982 Jun; 8(6):587-91. PubMed ID: 7139355
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuroendocrine measures of dopaminergic function in chronic cocaine users.
    Lee MA; Bowers MM; Nash JF; Meltzer HY
    Psychiatry Res; 1990 Aug; 33(2):151-9. PubMed ID: 2243892
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential effects of L-dopa and apomorphine on glucagon secretion in man: evidence against central dopaminergic stimulation of glucagon.
    Lorenzi M; Tsalikian E; Bohannon NV; Gerich JE; Karam JH; Forsham PH
    J Clin Endocrinol Metab; 1977 Dec; 45(6):1154-8. PubMed ID: 591612
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of desipramine and total sleep deprivation on hormonal levels of healthy subjects.
    Calil HM; Zwicker AP
    Psychiatry Res; 1987 Aug; 21(4):337-48. PubMed ID: 3628616
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of dopamine and neuroleptics on plasma growth hormone and prolactin in normal men.
    Langer G; Sachar EJ; Halpern FS
    Psychoneuroendocrinology; 1978 Apr; 3(2):165-9. PubMed ID: 704750
    [No Abstract]   [Full Text] [Related]  

  • 50. Dopaminergic sensitivity and cocaine abuse: response to apomorphine.
    Hollander E; Nunes E; DeCaria CM; Quitkin FM; Cooper T; Wager S; Klein DF
    Psychiatry Res; 1990 Aug; 33(2):161-9. PubMed ID: 2243893
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dopamine receptor sensitivity in the hypothalamus of chronic schizophrenics after haloperidol therapy: growth hormone and prolactin response to stimuli.
    Brambilla F; Bellodi L; Negri F; Smeraldi E; Malagoli G
    Psychoneuroendocrinology; 1979 Oct; 4(4):329-39. PubMed ID: 523590
    [No Abstract]   [Full Text] [Related]  

  • 52. Sensitization and tolerance to apomorphine in men: yawning, growth hormone, nausea, and hyperthermia.
    Szechtman H; Cleghorn JM; Brown GM; Kaplan RD; Franco S; Rosenthal K
    Psychiatry Res; 1988 Mar; 23(3):245-55. PubMed ID: 3387500
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug-induced growth hormone and prolactin responses in schizophrenia research.
    Lal S; Nair NP; Iskandar HI; Thavundayil JX; Etienne P; Wood PL; Guyda H
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):631-7. PubMed ID: 6131495
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Self-inhibitory dopamine receptors: their role in the biochemical and behavioral effects of low doses of apomorphine.
    Di Chiara G; Corsini GU; Mereu GP; Tissari A; Gessa GL
    Adv Biochem Psychopharmacol; 1978; 19():275-92. PubMed ID: 358782
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of selective sleep deprivation on sleep-linked prolactin and growth hormone secretion.
    Beck U; Marquetand D
    Arch Psychiatr Nervenkr (1970); 1976 Dec; 223(1):35-44. PubMed ID: 1016017
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of dopaminergic receptors in the regulation of growth hormone secretion.
    Müller EE; Liuzzi A; Cocchi D; Panerai AE; Oppizzi G; Lacatelli V; Mantegazza P; Silvestrini F; Chiodini PG
    Adv Biochem Psychopharmacol; 1977; 16():127-38. PubMed ID: 142419
    [No Abstract]   [Full Text] [Related]  

  • 57. Differential actions of dopamine receptor subtypes on gonadotropin and growth hormone release in vitro in goldfish.
    Chang JP; Yu KL; Wong AO; Peter RE
    Neuroendocrinology; 1990 Jun; 51(6):664-74. PubMed ID: 2141920
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dopamine supersensitivity and hormonal status in puerperal psychosis.
    Meakin CJ; Brockington IF; Lynch S; Jones SR
    Br J Psychiatry; 1995 Jan; 166(1):73-9. PubMed ID: 7894880
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Apomorphine: chemistry, pharmacology, biochemistry.
    Colpaert FC; Van Bever WF; Leysen JE
    Int Rev Neurobiol; 1976; 19():225-68. PubMed ID: 13044
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of dopamine agents on schedule- and deprivation-induced drinking in rats.
    Snodgrass SH; Allen JD
    Pharmacol Biochem Behav; 1987 Jul; 27(3):463-75. PubMed ID: 3659069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.